International Stroke Conference 2021

Masked doctor with hologram report

Let's hear from you!

Submit your session suggestions for:
ISC 2022 and Stroke Nursing Symposium today!

Deadline to submit: April 26, 2021

Two healthcare professionals in white coats looking at data on a digital tablet.

What's New?

Featured Speakers

Click on a name below to follow the speaker during #ISC21.

Richard T. Benson, MD, PhD Jose Biller, MD, FAAN, FACP, FAHA
Richard T. Benson, MD, PhD
Racing to Greater Life Expectancy by 2030: Is Racism a Tangible Target to Achieve Cerebrovascular Health Equity?
Wednesday, March 17
12:00 p.m. – 12:45 p.m.

NINDS & Health Disparities in HEADS-UP 3: Public Outreach, Program Opportunities, and Pandemic Preparedness
Available OnDemand
Jose Biller, MD, FAAN, FACP, FAHA
Case Vignettes from the 2019 Update of the Guidelines for the Early Management of Acute Ischemic Stroke
Thursday, March 18
8:50 a.m. – 9:00 a.m.
Mitchell S. V. Elkind, MD, MS, FAAN, FAHA
AHA Presidential Address
Wednesday, March 17
10:35 a.m. – 11:00 a.m.
Michael D. Hill, MD, MSc Walter J. Koroshetz, MD Eliza C. Miller, MD
Michael D. Hill, MD, MSc
Thinking Clearly about Acute Ischemic Stroke Treatment
Wednesday, March 17
9:45 a.m. – 10:00 a.m.
Walter J. Koroshetz, MD
Health Disparities Research that Matters
Wednesday, March 17
8:07 a.m. – 8:27 a.m.
Eliza C. Miller, MD
Neuro-Obstetrics: Partnering to Prevent Maternal Neurological Morbidity and Mortality
Wednesday, March 17
9:30 a.m. – 9:45 a.m.

Award Recipients

Follow our #ISC21 Award Winners when they deliver their lectures by clicking their names below:

Marilyn J. Cipolla, PhD, FAHA Philip B. Gorelick, MD, MPH Bruce Ovbiagele, MD, MSc, MAS, MBA
Marilyn J. Cipolla, PhD, FAHA
Thomas Willis Lecture: Targeting Brain Arterioles for Acute Stroke Treatment
Available OnDemand
Philip B. Gorelick, MD, MPH
Edgar J Kenton III Lecture: Foundational Lessons Learned from the African-American Antiplatelet Stroke Prevention Study (AAASPS) & Studies of Dementia in the Black Aged (SDBA)
Wednesday, March 17
8:30 a.m. – 8:55 a.m.
Bruce Ovbiagele, MD, MSc, MAS, MBA
William M Feinberg Lecture: Cerebrovascular Health Inequities: Seeking Global Solutions
Available OnDemand
Kevin N. Sheth, MD, FAHA, FCCM, FNCS, FAAN, FANA Takenori Yamaguchi, MD
Outstanding Stroke Research Mentor Lecture: Personalized Medicine in Stroke Through Personalized Mentorship
Available OnDemand
Takenori Yamaguchi, MD
David G Sherman Lecture: Our Efforts for Ideal Stroke Prevention and Treatment in Japan
Available OnDemand

ISC 21 Abstract Award Recipients

CVSN Stroke Nursing Symposium Award
Ashok Kumar, PhD, MSN

Mordecai Y T Globus New Investigator Award in Stroke
Andreas Charidimou, MD, PhD

Robert G Siekert New Investigator Award in Stroke
Alexander Merkler, MD, MS

Stroke Basic Science Award
Xiaojing Shi, PhD

Stroke Care in Emergency Medicine Award
Katherine Mun, MD

Stroke Minority Award
Ancer Leal, BSN-RN, LMSW
Nicholas R. Lopez
Vanessa Torres

Stroke Rehabilitation Award
David Matchar, MD

Vascular Cognitive Impairment Award
Silvia Koton, PhD, RN

Late Breaking and OnGoing Clinical Trials

How to find these abstracts

Non-late breaking abstracts are published in the Stroke journal here: ISC 2021 Abstracts(link opens in new window).

However, abstracts for Late Breaking (LB) and OnGoing Clinical Trials (OGCT) publish at the start of their session.

Use the links below to visit the individual sessions on the planner, and from there you can click through to each LB or OGCT presentation. Please note each abstract will not publish until the start of its session or its presentation.

Late Breaking Trials

Wednesday, March 17

ME I. Opening Main Event
Wednesday, March 17, 2021, 10:30 am - 11:30 am

LB1. ANGIO-CAT: Evaluation of Direct Transfer to Angiography Suite vs. Computed Tomography Suite in Endovascular Treatment of Stroke: ANGIO-CAT Randomized Clinical Trial
LB2. BEST-MSU: Benefits of Stroke Treatment Delivered by a Mobile Stroke Unit Compared to Standard Management by Emergency Medical Services (BEST-MSU Study)

LB1. Late-Breaking Science Oral Abstracts I 
Wednesday, March 17, 2021, 8:00 am - 9:00 am

LB13. The RACECAT Pre-Hospital Protocol: Impact on Acute Stroke Workflow
LB14. CT Perfusion-Guided Patient Selection for Endovascular Treatment of Acute Ischemic Stroke: Results From the MR CLEAN Registry
LB15. Acute Ischemic Stroke in the Coronavirus Disease 2019 Era: An Analysis From Get With the Guidelines-Stroke
LB16. Telestroke: Maintaining Quality Acute Stroke Care During the Covid-19 Pandemic

LB2. Late-Breaking Science Oral Abstracts II
Wednesday, March 17, 2021, 8:00 am - 9:00 am

LB18. Low-Frequency Oscillations Detected With Diffuse Correlation Spectroscopy Are a Potential Biomarker for Cerebral Amyloid Angiopathy
LB19. Concerted Neuroprotection by a PAF-Receptor Antagonist Plus an Inflammatory Response Modulator in Experimental Ischemic Stroke
LB20. Pro-Homeostatic Docosanoids Exert Remarkable Neurological Recovery After Experimental Stroke
LB21. Stroke Disparities in Racial and Other Minorities: Results From the “All of Us” Research Program
LB22. Intensive Blood Pressure Lowering With Intravenous Nicardipine Immediately After Intracerebral Hemorrhage: A Systematic Review and Individual Patient Data Analysis

LB P1. Late-Breaking Science Posters
Wednesday, March 17, 2021, 8:00 am - 9:00 am

LBP1. Trevo® Retriever China Registry: Main Results
LBP2. Glycated Albumin Predicts Functional Outcome of Ischemic Stroke Patients Treated by IV tPA  
LBP3. Nationwide Patterns of Rapid CT Stroke Evaluation  
LBP4. Multiomic Mechanistic Discoveries in Neurovascular Disease, Cerebral Cavernous Angioma  
LBP5. Glycemic Gap Predicts In-Hospital Mortality in Intracerebral Hemorrhage Patients  
LBP6. Morphological Characterization of Stroke-Induced Pathology and Therapeutic Potential at the Neuromuscular Interface  
LBP7. Real-World Accuracy of Artificial Intelligence-Based Triage in Large Vessel Occlusion Stroke  
LBP8. Neurothrombectomy in Patients With Covid-19. A Systematic Review and Meta-Analysis  
LBP9. Predictor of Cerebral Ischemic Injury in Hereditary Hemorrhagic Telangiectasia Patients  
LBP10. Quality of Life Measures in Treatment Options for Prevention of Atrial Fibrillation Related Stroke  
LBP11. Endothelial Specific TXNIP Depletion Reduces Post-Stroke Hemorrhagic Transformation With Thrombolytic Therapy in Hyperglycemic Mice  
LBP12. Albumin Glycation in Diabetic Patients Enhances Release of Clotting Factors and Reduces Bioavailability of Antioxidants in Circulation  
LBP13. Altered Abundance of the Epitranscriptomic Mark M1A Following Focal Ischemia  
LBP14. Very Short Term Blood Pressure Variability and Outcome After Thrombectomy 
LBP15. Tacis Study: Troponin in Acute Ischaemic Stroke  
LBP16. Tenecteplase Non-Inferiority to Alteplase in Acute Ischemic Stroke: A P-Value Continuum Analysis  
LBP17. Association of Plasma Oxidation-Reduction Potential With Collateral Circulation Status in Patients With Middle Cerebral Artery Occlusions Treated With Endovascular Therapy  
LBP18. The Neurotrophin P75 Receptor Ligand, Lm11a-31, Improves Stroke Outcome in a Murine Model of Cerebral Ischemia  
LBP19. Characteristics of Patients With Resistant Hypertension and Premature Ischemic Stroke  
LBP20. Low Muscle Mass at Admission Predicts Poor Walking Function at Discharge in Patients With Anterior Circulation Stroke Not in Posterior Circulation Stroke  
LBP21. The Effects of Forced Exercise on Gait and Cortical Activation Post-Stroke  
LBP23. Type-I Diabetes Aggravates Post-Hemorrhagic Stroke Cognitive Impairment by Augmenting Oxidative Stress and Neuroinflammation in Mice  
LBP24. Clinical and Demographic Characteristics, Natural History and Outcomes in Patients With Moyamoya Vasculopathy in the Canadian Population  
LBP25. Neutrophil-To-Lymphocyte Ratio as a Tool For Predicting Intraventricular Hemorrhage and Functional Outcome in Primary Intracerebral Hemorrhage  
LBP26. Characteristics of a Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy Cohort at Loyola University Chicago  
LBP27. Inter-Limb Coordination in Chronic Stroke Survivors  
LBP28. Improving the Quality of Anesthetic Management for Endovascular Thrombectomy: A Single Center Experience  
LBP29. Structured Nutritional Support Pathway Using Predictive Swallowing Score to Guide Decision-Making With Post-Stroke Dysphagia  
LBP30. Clinical Characteristics and Factors Relating to Poor Outcome on Patients With Aneurysmal Subarachnoid Hemorrhage in Vietnam  
LBP31. Vastus Lateralis Oxygen Consumption During a Graded Exercise Test in Chronic Stroke Survivors  
LBP32. Self-Efficacy After Stroke: Validation of Psychometric Properties of a Translated Chinese Version of Participation Strategies Self-Efficacy Scale  
LBP33. Peer Support Interventions in Stroke Care: A Systematic Review and Meta-Analysis  
LBP34. Late Presenter Thrombolysis for Ischemic Stroke: CT Perfusion for Patient Selection Between 4.5 to 24 Hours After Stroke Onset  
LBP35. Barriers to Access Endovascular Treatment for Acute Ischemic Stroke in the Health Care System of Mexico  
LBP36. A Novel Ballet-Inspired Home Exercise Package to Improve Balance and Gait in Stroke Survivors  
LBP37. Acute Antibiotics Treatment Curtails Post-Stroke Brain Damage  
LBP38. Dl-3-n-Butylphthalidealleviatescerebral Ischemia/Reperfusion Injury via the Activation of Cox7c in Vascular Endothelial Cells  
LBP39. The Prevalence of Prediabetes in Stroke  
LBP40. Primary Prevention of Carotid Stroke- The Spencer/Reid Curve and the Circle of Willis
LBP41. Preventing Air During CABG to Minimize Risk of Neurologic Complications Postoperatively

Thursday, March 18

ME II. Thursday Main Event
Thursday, March 18, 2021, 10:30 am - 11:30 am

LB3. MR CLEAN-NO IV: Intravenous Thrombolysis Followed by Endovascular Thrombectomy versus Direct Endovascular Thrombectomy: A Randomized Controlled Trial
LB4. SHRINE Systemic Thrombolysis Randomization In Endovascular Stroke Therapy (SHRINE) Collaboration
LB5. Secondary Analysis of the Racecat Trial: Benefit of Direct Transfer to an Endovascular Stroke Center According to the Presence of Large Vessel Occlusion and the Transfer Time to the Endovascular Center
LB6. STROKE AF: Atrial Fibrillation in Non-Cardioembolic Stroke of Presumed Known Origin
LB7. ReMEDy: Safety and Tolerability of Recombinant Human Tissue Kallikrein (DM199) in Acute Ischemic Stroke: The ReMEDy Randomized Clinical Trial

Friday, March 19

ME III. Closing Main Event
Friday, March 19, 2021, 10:30 am - 11:30 am

LB8. Thrombectomy for Anterior Circulation Stroke Beyond 6 Hours From Time Last Known Well: Final Results of the Aurora (Analysis of Pooled Data From Randomized Studies of Thrombectomy More Than 6 Hours After Last Known Well) Collaboration
LB9. National Temporal Trends in Endovascular Therapy (EVT) Utilization and Outcomes According to Race and Ethnicity: Findings From Get With the Guidelines (GWTG)-Stroke
LB10. TIGER: A New Class of Radially-Adjustable Stentrievers for Acute Ischemic Stroke: Primary Results of the Multicenter Tiger Trial
LB11. VERITAS: Vertebrobasilar Occlusion Randomization to Endovascular Reperfusion versus Intravenous Thrombolysis or Medical Treatment Alone Systematic Evaluation (VERITAS) Collaboration
LB12. Stroke Among Patients Hospitalized With COVID-19 in the United States: Results From the AHA COVID-19 Cardiovascular Disease Registry

OnGoing Clinical Trials


Wednesday, March 17

CT P1. Ongoing Clinical Trials Posters
Wednesday, March 17, 2021, 8:00 am - 9:00 am

CTP1. Multi-arm Optimization Of Stroke Thrombolysis (most)
CTP2. Dual Thrombolytic Therapy With Mutant Pro-urokinase And Low Dose Alteplase For Ischemic Stroke (DUMAS)
CTP3. Mr Clean-med: The Effect Of Periprocedural Medication Inpatients Undergoing Intra-arterial Treatment For Acute Ischemic Stroke: Antiplatelet Agents, Heparin, Both Or Neither
CTP4. Endovascular Acute Stroke Intervention - Tandem Occlusion Trial (EASI-TOC): A Trial Of Acute Cervical Internal Carotid Artery Stenting During Endovascular Thrombectomy For Anterior Circulation Stroke
CTP5. Outcome In Patients Treated With Intraarterial Thrombectomy - Optimal Blood Pressure Control (optimal-bp) Study
CTP6. Atrial Cardiopathy And Antithrombotic Drugs In Prevention After Cryptogenic Stroke
CTP7. Transcranial Direct Current Stimulation For Post-stroke Motor Recovery - A Phase II Study (TRANSPORT2)
CTP8. ENDOLOW Clinical Trial
CTP9. Edoxaban For Intracranial Hemorrhage Survivors With Atrial Fibrillation: Design Of A Global Randomized Trial
CTP10. MultiStem Administration For Stroke Treatment To Enhance Recovery Study-2: Pivotal Phase 3 Trial Evaluating The Efficacy And Safety Of An Adult Cell Therapy Product In Treatment Of Ischemic Stroke
CTP11. The I-acquire Trial Of Rehabilitation For Perinatal Stroke
CTP12. Randomization To Extend Stroke Intravenous Thrombolysis In Evolving Non-large Vessel Occlusion With Tnk (resilient- Extend-iv)
CTP13. Optimal Blood Pressure For The Prevention Of Major Vascular Events In Stroke Patients (optimal-stroke) And Diabetic Patients (optimal-diabetes)- The Optimal Mind Substudy
CTP15. Protocol For Laser: Lixiana Acute Stroke Evaluation Registry - A Randomized Controlled Trial With An Associated Registry Of Early Anticoagulation After Ischemic Stroke In Patients With Atrial Fibrillation
CTP16. Robotic Tcd Ultrasound Bubble Study Compared To Transthoracic Echocardiography For Detection Of Right To Left Shunt (bubl)
CTP17. Transcranial Electrical Stimulation (tdcs) In Stroke Early After Onset Clinical Trial (tesseract)
CTP18. The Two-decade Trajectory Of The Japan Stroke Data Bank (JSDB)
CTP19. Sleep For Stroke Management And Recovery Trial
CTP20. Recombinant Factor VIIa For Acute Hemorrhagic Stroke Administered At Earliest Time (FASTEST) Trial
CTP21. The NIH StrokeNet Trials Implementation
CTP22. Anticoagulation In Intracerebral Hemorrhage (ich) Survivors For Stroke Prevention And Recovery
CTP23. CREST 2 Update
CTP24. Blood Pressure After Endovascular Stroke Treatment (BEST)-II: A Randomized Clinical Trial
CTP25. SECRET: Study Of Rivaroxaban In Cerebral Venous Thrombosis

#ISC21 Schedule-at-a-Glance

Here are some of the highlighted planned activities in store at International Stroke Conference 2021.

Wednesday, March 17

7:00 - 7:45 a.m.
Move More Fitness and Dance Breaks (Recorded)
7:45 - 8:00 a.m.
8:00 - 9:00 a.m.
LIVE Simu-live Simu-live
194. HEADS-UP Opening Session: Pre-Test
VHealth Disparities Research that Matters: Walter J. Koroshetz
Kenton Lecture: Philip B. Gorelick
187. COVID-19 Debates: General Anesthesia vs Conscious Sedation? / Coagulopathy or Endotheliopathy? 11. Mismatch Misalignments for Extended-window IV-thrombolysis for Non-Large Vessel Occlusion Strokes (Debate)
9:00 - 9:15 a.m.
9:15 - 10:15 a.m.
LIVE Simu-live Simu-live
191. CED Talks (Cerebrovascular Education and Discovery) NS ME. Nursing Symposium: Let's Talk About Race 48. I Swear to Treat the Stroke, the Whole Stroke, and Nothing but the Stroke
10:15 - 10:30 a.m.
10:30 - 11:30 a.m.
LIVE Simu-live Simu-live
LIVE: Opening Main Event
CEO Welcome: Nancy Brown
AHA Presidential Address: Mitch Elkind
Late-Breaking Science Abstracts
135. The Leptomeningeal Collaterals: Understanding Their Specialized Function and Regulation in the Context of Stroke 172. Clinical Considerations in Acute Hypertension Management
11:30 a.m. - 1:00 p.m.
Break and/or News Media events
12:00 p.m. - 12:45 p.m.
LIVE Simu-live Simu-live
199. Racing to Greater Life Expectancy by 2030: Is Racism a Tangible Target to Achieve Cerebrovascular Health Equity? 
An ASA Special Session
1:00 - 4:45 p.m.
Industry Events / News Media Events / Learning Studios / Fireside Chats
4:45 - 5:00 p.m.
5:00 - 6:30 p.m.
Zoom Meeting Zoom Meeting Zoom Meeting
HEADS-UP Career Development Session: "Think Tank" Council Networking Session Council Networking Session

Thursday, March 18

7:00 - 7:45 a.m.
Move More Fitness and Dance Breaks (Recorded)
7:45 - 8:00 a.m.
8:00 - 9:00 a.m.
LIVE Simu-live Simu-live
68. Case Vignettes from the 2019 Update of the Guidelines for the Early Management of Acute Ischemic Stroke 66. Review of the Oversights of Comprehensive Nursing 137. Where We Are Going, Do We Need Roads? Discussing the Future of Neuroprotection in Stroke
9:00 - 9:15 a.m.
9:15 - 10:15 a.m.
LIVE Simu-live Simu-live
183. Is This Clot-Busting Agent Ready for Clinical Practice? (Debate) 27. Post-Stroke Cognitive Impairment and Dementia: A Global Effort 19. The Unruptured Aneurysm – Follow, Treat, Refer? (Debate)
10:15 - 10:30 a.m.
10:30 - 11:30 a.m.
LIVE Simu-live Simu-live
Thursday Main Event
Late-Breaking Science Abstracts
PBS Stroke Film Trailer
121. Enriched Environments and Recovery 141. Planes, Teams, and Automobiles: Going the Distance for the Acute Stroke Patient
11:30 a.m. - 1:00 p.m.
Break and/or News Media events
1:00 - 4:45 p.m.
Industry Events / News Media Events / Learning Studios / Fireside Chats
4:45 - 5:00 p.m.
5:00 - 6:30 p.m.
Zoom Meeting Zoom Meeting Zoom Meeting
HEADS-UP Career Development Session: "Building Momentum" Council Networking Session Council Networking Session

Friday, March 19

7:00 - 7:45 a.m.
Move More Fitness and Dance Breaks (Recorded)
7:45 - 8:00 a.m.
8:00 - 9:00 a.m.
LIVE Simu-live Simu-live
34. In the Age of Thrombectomy Does Thrombolysis Have a Role in LVO Treatment? (Debate) 23. CT, CTA, Perfusion, or Multiphase CTA in the Spoke versus the Hub: Optimal Acute Stroke Evaluation (Debate) 188. Prevention of Stroke in COVID-19 Patients 
9:00 - 9:15 a.m.
9:15 - 10:15 a.m.
LIVE Simu-live Simu-live
13. To Treat or Not to Treat - and If So, How? Up-to-date Perspective on the Treatment of Cervical Carotid High-degree Stenosis (Debate) 61. Data, Big Data, Biggest Data and Stroke 21. Knowns and Unknowns in Intracerebral Hemorrhage Treatment
10:15 - 10:30 a.m.
10:30 - 11:30 a.m.
LIVE Simu-live Simu-live
Closing Main Event
Late-Breaking Science Abstracts
ISC Program Chair's Closing Remarks
116. Prognostication and Early Withdrawal of Care in Ischemic Stroke and ICH 58. Sleep and Brain Health: Time to Wake Up to the Risks?
11:30 a.m. - 1:00 p.m.
Break and/or News Media events
1:00 - 4:45 p.m.
Industry Events / News Media Events / Learning Studios / Fireside Chats
4:45 - 5:00 p.m.
5:00 - 6:30 p.m.
Zoom Meeting Zoom Meeting
Council Networking Session Council Networking Session

Available OnDemand

Any time

These sessions will be available on demand during meeting:

  • Challenging EVT decision making – when, where, and who to treat (Debate)
  • Treatment of acute stroke in childhood and young adults (Debate)
  • Advanced Imaging in Intracranial Atherosclerotic Disease: Misnomer or Game-Changer?
  • Bridging Gaps in Preclinical Stroke Rehabilitation & Recovery Research: Translational Impact
  • Challenges in managing Raised ICP and Cerebral Edema in Stroke
  • Circadian Variation in Stroke: Mechanistic and Therapeutic Implications
  • COVID-19 and Stroke: An International Perspective
  • Crisis Management and Disaster Preparedness in COVID-19
  • Early Mobility: Myths, Facts and Evolving Science
  • Epidemiology and Pathophysiology of COVID-19
  • HEADS-UP 1 - "Worth the Work": Partnering with the Community to Reduce Disparities
  • HEADS-UP 2 - Community-Based Clinical Trials Across the Continuum of Care
  • HEADS-UP 3 - Public Outrach, Program Opportunities, and Pandemic Preparedness
  • How aneurysms are born, grow and mature – the latest in aneurysm biology
  • ISC 2021 Award Lectures: Feinberg, Willis, Sherman and Stroke Mentoring Award Lectures
  • Infection and Inflammation as Risk Factors for Stroke in Children and Adults
  • New Frontiers in Endovascular Therapy
  • Paola De Rango Memorial Session on Stroke in Women: The Association of Hormones with Stroke Risk Across Women of Different Ages and Race-Ethnicities
  • Pathophysiology and Neurological Manifestations of COVID-19
  • Physically Distanced Rehabilitation: Fad or Future?
  • Stroke and Depression: Pragmatic Approach to Diagnosis and Evidence Based Treatment
  • Stroke in Pregnancy: What To Expect When They’re Expecting
  • Stroke Motor Rehabilitation Challenges Across the Life Span: Similarities and Differences Between Infants and Adults
  • Stroke: High Impact Articles in Post-stroke Outcomes 2020 (a Stroke Journal Session)
  • Substance Abuse in Stroke
  • The Global Management of High Blood Pressure for the Prevention of Stroke: Joint Session from World Hypertension League and World Stroke Organization
  • Therapeutic approaches for cerebral amyloid angiopathy and related hemorrhagic stroke
  • Treatment of Acute Stroke in Patients with COVID-19: Case Studies
  • Validation Results from the MarkVCID Cerebral Small Vessel Disease Biomarkers Consortium
  • Improving Care of Patients Undergoing TransRadial (TR) Band
  • Re-engineering Staff Education
  • Results from the PATH2Caregiving Program and Future Directions of Stroke Caregiving
  • Acute Nonendovascular Treatment Oral Abstracts
  • Brain Health Oral Abstracts
  • Cerebrovascular Manifestations of COVID-19 Oral Abstracts
  • Cerebrovascular Systems of Care Oral Abstracts
  • Clinical Rehabilitation and Recovery Oral Abstracts
  • Health Services, Quality Improvement, and Patient-Centered Outcomes Oral Abstracts
  • Imaging Oral Abstracts
  • Intracerebral Hemorrhage Oral Abstracts
  • Late-Breaking Science Oral Abstracts I
  • Late-Breaking Science Oral Abstracts II
  • Neuroendovascular Oral Abstracts
  • Nursing Symposium Oral Abstracts
  • Pediatric Cerebrovascular Disease Oral Abstracts
  • Risk Factors and Prevention Oral Abstracts
  • Translational Basic Science Oral Abstracts
  • Moderated ePoster Sessions
  • ePoster Sessions


Key Dates

Date Event
Dec. 16, 2020 Registration begins for attendees and speakers
Jan. 13, 2021 Registration begins for groups and exhibitors
Feb. 8, 2021 Registration begins for news media
Mar. 17–19, 2021 International Stroke Conference 2021

Why you should attend #ISC21

The International Stroke Conference is the world’s premier meeting dedicated to the science and treatment of cerebrovascular disease. From forming multiple, life-long collaborations with the best minds in the profession to hearing the very latest big trial results to the exceptional education and science, if you are involved in the stroke medical profession, ISC is essential to your career.

This three-day virtual conference features more than 1,300 compelling presentations in 17 categories that emphasize basic, clinical and translational sciences as they evolve toward a better understanding of stroke pathophysiology with the goal of developing more effective therapies.

For the virtual meeting this year, there will be a combination of both live and OnDemand-only invited and oral abstract sessions; the exciting ePosters and Moderated ePosters will be available online beginning March 17th. During the live sessions, you can submit your questions to the presenters and also participant in the presenter polls. ePosters offer you the opportunity to submit your questions to be answered by the abstract presenter. In addition, all of the sessions will be available OnDemand for registered attendees to access at their convenience until April 16, 2021.

This conference provides the opportunity to network with thousands of colleagues in the stroke field from around the world with wide-ranging expertise and experience.

Clinical Sessions focus on risk factors and prevention; cerebrovascular systems of care; imaging; neuroendovascular; acute nonendovascular treatment; non-acute large vessel disease from veins to arteries; in-hospital care, from the ICU to discharge; clinical rehabilitation and recovery; and health services, quality improvement, and patient-centered outcomes.

Basic Science sessions focus on translational basic science.

Further specialized topics include cerebrovascular manifestations of COVID-19; brain health; intracerebral hemorrhage; cerebrovascular nursing; advanced practice providers and therapists; pediatric cerebrovascular disease; aneurysms and vascular malformations; and ongoing clinical trials.

Presentations on these topics attract a wide range of healthcare professionals and investigators including adult and pediatric neurologists; neurosurgeons; neuroradiologists and interventional radiologists; physiatrists; emergency medicine specialists; primary care physicians; hospitalists; nurses and nurse practitioners; rehabilitation specialists; physical, occupational, and speech therapists; pharmacists; and basic researchers spanning the fields of cerebrovascular function and disease.

Additional Resources

Policies & Procedures

Following is a list of key policies and procedures strongly enforced at the International Stroke Conference.

Registration Fee Policy

Registration for ISC 2021 is non-refundable. However, registrants will have access to any sessions they missed OnDemand through April 16, 2021.

Policy of Recording

Unauthorized recording of the AHA Scientific Sessions, scientific conferences and the AHA/ASA International Stroke Conference is prohibited, whether by video, still or digital photography, audio or any other recording or reproduction mechanism. This includes recording of presentations and supporting audiovisual materials, poster presentations and supporting poster materials. The American Heart Association and America Stroke Association reserve the rights to all recordings or reproductions of presentations at AHA/ASA scientific conferences and meetings. Check the program for information about the availability of videotapes or audiotapes for purchase. Exceptions to this policy prohibition are:

  • Audiotape recording for strictly personal and non-commercial use is permitted if not disruptive; and exhibitors may photograph their own booth for promotional purposes upon prior written consent of the AHA/ASA.

During the International Stroke Conference, attendees, vendors, guests and others may be photographed and videotaped by AHA/ASA vendors in capturing the event. Some of these photographs or videos may be displayed by the AHA/ASA in future publications or materials connected with the event. If you do not wish for your image to be displayed by the AHA/ASA, please contact the AHA/ASA in writing at 7272 Greenville Avenue, Dallas, TX 75231, Att: International Stroke Conference Meetings Department, no later than two weeks after the meeting.

AHA Harassment Policy

The AHA requires that all faculty, attendees, exhibitors, presenters, contractors, vendors and volunteers of this AHA meeting comply with all federal, state and local laws and regulations, including those that prohibit harassment and discrimination against individuals based on their race, color, religion, sex, sexual orientation, gender identity or national origin.